Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.
Keywords: Computed tomography (CT); Incidental adrenal nodule; Merit-based Incentive Payment Systems (MIPS); Pheochromocytoma.